Close Menu

private financing

The firm has opened a $10 million Series A financing round that it expects to close in late summer to support running clinical studies for its assay.

The Beverly, Massachusetts-based company plans to use the funding to expand its PlexWell sequencing library prep technology into new areas.

The firm said it will use the funds to advance development of its HostDx immune response gene expression tests for acute infections and sepsis.

The Church Lab spinout has now raised more than $50 million to develop and commercialize its fluorescent in situ sequencing technology for spatial genomics.

The San Diego-based company plans to develop a flexible, modular, and high-performing sequencing platform based on proprietary technologies in different areas.

The San Diego firm has now raised at least $145 million to drive development of its DNA sequencing platform and build manufacturing and commercial operations.

The additional funds follow the $25 million that the company announced in May 2019, bringing the total figure for the round to $45 million.

The Durham, North Carolina-based startup will use the funds to develop a library preparation kit for single-cell sequencing.

The University of Washington spinout will use the funding to commercialize duplex sequencing technology to detect low-frequency DNA mutations.

The UK-based sequencing technology firm raised £29.3 million in capital and sold £80.2 million in secondary shares.

Pages

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.